Serrano, Alejandro
Casares, Noelia
Trocóniz, Iñaki F.
Lozano, Teresa
Lasarte, Juan J.
Zalba, Sara
Garrido, María J.
Article History
Received: 9 January 2024
Accepted: 6 June 2024
First Online: 29 July 2024
Competing interests
: NC and JJL are co-inventors of patents for the use of P60 as a Treg inhibitor; patent numbers ES 200703052, ES 201230309, EP 16195686.7. The remaining authors have no conflicts of interest to declare.
: All experiments were performed according to European animal care regulations and ARRIVE guidelines, and the protocol was approved by the Ethics Committee of the University of Navarra (Ref. 023-17). Human endpoints and animal welfare have been carefully observed all over the in vivo studies. Experiments with human samples were approved by the Institutional Ethics Committee (Ref. 2022/093).
: All authors gave their consent for publication.